EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Knight Therapeutics Inc. (T.GUD) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
-9.12M |
|
-- |
|
-- |
|
-- |
|
-2.65M |
|
-- |
|
-11.28M |
|
-11.28M |
|
-9.12M |
|
-9.12M |
|
-9.12M |
|
-9.12M |
|
-2.65M |
|
6.12M |
|
99.63M |
|
99.63M |
|
-0.09 |
|
-0.09 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
750.30M |
|
-- |
|
-- |
|
-- |
|
198.71M |
|
551.59M |
|
208.30M |
|
551.59M |
|
99.65M |
|
| Cash Flow Statement Financials | |
17.29M |
|
-50.00M |
|
33.33M |
|
57.91M |
|
56.25M |
|
-1.66M |
|
2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
0.10 |
|
0.14 |
|
41.76% |
|
-3.42% |
|
-3.42% |
|
|
EBITDA Margin |
-- |
-14.54% |
|
-11.76% |
|
16.60M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.42 |
|
1.00 |
|
90.29 |
|
-1.65% |
|
-4.38% |
|
-1.22% |
|
-1.49% |
|
7.66 |
|
0.17 |
|
0.17 |
|